Astrana Health Inc (ASTH)vsUniversal Health Services Inc (UHS)
ASTH
Astrana Health Inc
$37.99
+0.37%
HEALTHCARE · Cap: $1.87B
UHS
Universal Health Services Inc
$145.17
+1.72%
HEALTHCARE · Cap: $8.86B
Smart Verdict
WallStSmart Research — data-driven comparison
Universal Health Services Inc generates 404% more annual revenue ($17.76B vs $3.53B). UHS leads profitability with a 8.6% profit margin vs 0.9%. UHS trades at a lower P/E of 6.1x. UHS earns a higher WallStSmart Score of 70/100 (B).
ASTH
Buy56
out of 100
Grade: C
UHS
Strong Buy70
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+89.9%
Fair Value
$188.57
Current Price
$37.99
$150.58 discount
Margin of Safety
-29.7%
Fair Value
$178.30
Current Price
$145.17
$33.13 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 55.6% year-over-year
Earnings expanding 110.1% YoY
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Every $100 of equity generates 20 in profit
Areas to Watch
Smaller company, higher risk/reward
ROE of 3.8% — below average capital efficiency
0.9% margin — thin
Operating margin of 3.0%
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : ASTH
The strongest argument for ASTH centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 55.6% demonstrates continued momentum.
Bull Case : UHS
The strongest argument for UHS centers on P/E Ratio, Price/Book, Return on Equity. PEG of 1.02 suggests the stock is reasonably priced for its growth.
Bear Case : ASTH
The primary concerns for ASTH are Market Cap, Return on Equity, Profit Margin. A P/E of 61.7x leaves little room for execution misses. Thin 0.9% margins leave little buffer for downturns.
Bear Case : UHS
No major red flags identified for UHS, but monitor valuation.
Key Dynamics to Monitor
ASTH profiles as a hypergrowth stock while UHS is a value play — different risk/reward profiles.
UHS carries more volatility with a beta of 1.08 — expect wider price swings.
ASTH is growing revenue faster at 55.6% — sustainability is the question.
UHS generates stronger free cash flow (184M), providing more financial flexibility.
Bottom Line
UHS scores higher overall (70/100 vs 56/100). ASTH offers better value entry with a 89.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Astrana Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Universal Health Services Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?